June 3rd 2023
Intelligent Retinal Imaging Systems (IRIS) celebrates the company’s 1 millionth diabetic retinal exam.
PALADIN 3-year results: Fluocinolone acetonide intravitreal implant improves visual acuity, CST
February 24th 2022Alimera Sciences, Inc. announces statistically significant improvements in best corrected visual acuity, central subfield thickness and treatment burden for patients with diabetic macular edema.
Determining the time to DME resolution with intravitreal aflibercept
October 9th 2021Speaking at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Rishi P. Singh, MD, provided results of the VISTA and VIVID studies, and he pointed out that the findings could help physicians set expectations of DME therapy.